HER2
HER2 is a member of the epidermal growth factor. It initiates the EGF downstream cascade by forming a heterodimer with other ligand-bound EGF receptor. It is associated with breast and ovarian cancers.
Products for HER2
- Cat.No. Product Name Information
- GC13257 AC480 (BMS-599626) AC480 (BMS-599626) (AC480) is a selective and orally bioavailable HER1 and HER2 inhibitor, with IC50s of 20 and 30 nM, respectively. AC480 (BMS-599626) displays ~8-fold less potent to HER4 (IC50=190 nM), >100-fold to VEGFR2, c-Kit, Lck, MEK. AC480 (BMS-599626) inhibits tumor cell proliferation, and has potential to increase tumor response to radiotherapy.
- GC10707 Afatinib dimaleate An inhibitor of EGFR and ErbB2
- GC10606 BMS-599626 Hydrochloride
- GC12087 Canertinib dihydrochloride A pan-ErbB tyrosine kinase inhibitor
- GC13091 CP-724714 HER2 inhibitor,potent and selective
- GC16008 CUDC-101 A multi-target inhibitor of HDACs, EGFR, and HER2
- GC10250 Mubritinib (TAK 165) Mubritinib (TAK 165) (TAK-165) is a potent and selective EGFR2/HER2 inhibitor with an IC50 of 6 nM.
- GC10362 Neratinib (HKI-272) Neratinib (HKI-272) (HKI-272) is an orally available, irreversible, highly selective HER2 and EGFR inhibitor with IC50s of 59 nM and 92 nM, respectively.
- GC17473 Pelitinib (EKB-569) Pelitinib (EKB-569) (EKB-569;WAY-EKB 569) is an irreversible inhibitor of EGFR with an IC50 of 38.5 nM; also slightly inhibits Src, MEK/ERK and ErbB2 with IC50s of 282, 800, and 1255 nM, respectively.
- GC17916 Poziotinib A irreversible pan-HER inhibitor
- GC11172 TAK-285 HER2/EGFR(HER1) inhibitor
- GC15271 Tyrphostin AG 879 HER2 inhibitor